All News #Library
Rare Diseases
FDA Rejects Aldeyra Eye Disease Candidate for 3rd Time
17 Mar 2026 //
FIERCE BIOTECH
Aldeyra Therapeutics Granted EMA Orphan Status for ADX-2191
28 Aug 2025 //
PHARMAWEB
Aldeyra Gets Fast Track For ADX-2191 In Retinitis Pigmentosa
19 Aug 2025 //
BUSINESSWIRE

Market Place
Sourcing Support